to phenylalanine resulted in a 30% diminution in RGS16 GAP activity but completely eliminated its ability to regulate G i -mediated MAPK activation or adenylyl cyclase inhibition in HEK 293T cells. In contrast, mutation of Tyr 177 to phenylalanine had no effect on RGS16 GAP activity but also abolished its regulation of G i -mediated signal transduction in these cells. These data suggest that tyrosine phosphorylation regulates RGS16 function and that EGFR may potentially inhibit G␣ i -dependent MAPK activation in a feedback loop by enhancing RGS16 activity through tyrosine phosphorylation.
G␣ i -coupled receptor stimulation results in epidermal growth factor receptor (EGFR) phosphorylation and MAPK activation. Regulators of G protein signaling (RGS proteins) inhibit G protein-dependent signal transduction by accelerating G␣ i GTP hydrolysis, shortening the duration of G protein effector stimulation. RGS16 contains two conserved tyrosine residues in the RGS box, Tyr 168 and Tyr 177 , which are predicted sites of phosphorylation. RGS16 underwent phosphorylation in response to m2 muscarinic receptor or EGFR stimulation in HEK 293T or COS-7 cells, which required EGFR kinase activity. Mutational analysis suggested that RGS16 was phosphorylated on both tyrosine residues (Tyr 168 > > Tyr 177 ) after EGF stimulation. RGS16 co-immunoprecipitated with EGFR, and the interaction did not require EGFR activation. Purified EGFR phosphorylated only recombinant RGS16 wild-type or Y177F in vitro, implying that EGFR-mediated phosphorylation depended on residue Tyr 168 . Phosphorylated RGS16 demonstrated enhanced GTPase accelerating (GAP) activity on G␣ i . Mutation of Tyr 168 to phenylalanine resulted in a 30% diminution in RGS16 GAP activity but completely eliminated its ability to regulate G i -mediated MAPK activation or adenylyl cyclase inhibition in HEK 293T cells. In contrast, mutation of Tyr 177 to phenylalanine had no effect on RGS16 GAP activity but also abolished its regulation of G i -mediated signal transduction in these cells. These data suggest that tyrosine phosphorylation regulates RGS16 function and that EGFR may potentially inhibit G␣ i -dependent MAPK activation in a feedback loop by enhancing RGS16 activity through tyrosine phosphorylation.
RGS
1 proteins have emerged as important contributors to the kinetic precision associated with heterotrimeric G protein signaling (reviewed in Ref. 1) . Genetic evidence in lower eukaryotes suggests that RGS proteins are negative regulators of G protein-coupled signal transduction (2, 3) , which is consistent with their GAP activity and inhibition of G protein-dependent second messenger activation in mammalian cells (4 -7) . Many tissues and cell types contain several RGS proteins that possess similar GAP activity toward both G␣ i and G␣ q in vitro (8, 9) . This phenomenon provokes the question of whether some RGS proteins are redundant, and if so, how RGSs are differentially regulated within a given cell to modify a particular G protein or G protein-coupled receptor (GPCR) pathway.
RGS activity may be modulated by transcriptional induction (6, 10, 11) , subcellular localization (12) (13) (14) , and post-translational modification (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . For instance, RGS4 and RGS16 are palmitoylated in Saccharomyces cerevisiae, but this modification is not required for plasma membrane association or regulation of pheromone signaling (15, 16) . RGS4, RGS7, and RGS10 expressed in Sf9 cells are palmitoylated on conserved cysteine residues, including one in the RGS box (Cys 95 in RGS4, Cys 66 in RGS10). In the case of RGS7, palmitoylation occurs only in the membrane-associated fraction (17, 18) . Palmitoylation of the RGS box cysteine in RGS4 or RGS10 either inhibits or potentiates GAP activity depending on how GTP hydrolysis is measured (single turnover versus receptorstimulated activity in proteoliposomes) (17, 19) . In HEK 293T cells, palmitoylation of conserved amino-terminal cysteine residues in RGS16 (Cys 2 , Cys 12 ) does not affect its membrane attachment but is required for its ability to modulate both G␣ iand G␣ q -mediated signaling (20) . Collectively, these studies indicate that regulation of RGS activity by a covalent modification such as palmitoylation is likely to be complex.
RGS proteins may also be modified by Ser/Thr phosphorylation. The yeast RGS protein Sst2 undergoes pheromone-induced phosphorylation by MAPK, which slows its degradation (21) . RGS7 is phosphorylated on a conserved Ser residue by protein kinase C, which promotes interaction with 14-3-3 proteins and inhibition of RGS7 GAP activity (22) . Similarly, protein kinase C-induced phosphorylation inhibits RGS2 GAP activity on G␣ q (23) .
In contrast, ERK2 phosphorylates RGS-G␣-interacting protein, which enhances its capacity to act as a GAP on G␣ i3 (24) . Protein kinase A phosphorylates RGS10, which does not affect GAP activity but correlates with RGS10 translocation from the plasma membrane and cytosol to the nucleus (25) . RGS9 -1 undergoes Ser phosphorylation by an unidentified endogenous kinase in rod outer segments (26) . Finally, RGS16 is phosphorylated on Ser-194 after epinephrine stimulation of cells expressing the ␣2A-adrenergic receptor (27) . Mutation of this serine residue to alanine impairs RGS16 GAP activity and its regulation of epinephrine-stimulated MAPK activity in these cells, but the direct effect of RGS16 Ser phosphorylation on its GAP activity has not been determined.
The current study shows that RGS16 GAP activity is regulated by phosphorylation of conserved tyrosine residues (Tyr 168 and Tyr 177 ) in the RGS box. EGFR phosphorylated RGS16 directly, which depended on the presence of residue Tyr 168 , * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ To whom correspondence should be addressed: Molecular Signal Transduction Section, Laboratory of Allergic Diseases, National Institutes of Health, 12441 Parklawn Dr., Rockville, MD 20852. Tel.: 301-435-8875; Fax: 301-402-7271; E-mail: kdruey@nih.gov. 1 The abbreviations used are: RGS, regulator of G protein signaling; GPCR, G protein-coupled receptor; RTK, receptor tyrosine kinase; HA, hemagglutinin epitope of Influenza virus; GAP, GTPase-activating protein; MAPK, mitogen-activated protein kinase; EGFR, epidermal growth factor receptor; WT, wild-type; BSA, bovine serum albumin; Ab, antibody; ERK, extracellular signal-regulated kinase. because mutation of this residue to phenylalanine abolished EGFR-mediated phosphorylation in vitro. The Y168F mutation also diminished RGS16 GAP activity. RGS16 (Y177F) underwent phosphorylation similar to WT RGS16 after EGF stimulation and demonstrated normal GAP activity. However, neither tyrosine mutant effectively regulated G i -GPCR-mediated MAPK activation or inhibition of adenylyl cyclase in vivo, suggesting that tyrosine phosphorylation is important for RGS16 function. EGFR-mediated phosphorylation of RGS16 suggests a novel form of cross-talk between receptor tyrosine kinase and G protein-coupled signaling pathways.
EXPERIMENTAL PROCEDURES
Cells, Proteins, and Plasmids-HEK 293T cells were maintained in supplemented Dulbecco's modified Eagle's medium (Invitrogen/Life Technologies) containing 10% fetal bovine serum, 2 mM L-glutamine, 100 units/ml penicillin, 100 units/ml streptomycin, and 20 ng/ml gentamicin, in a humidified 5% CO 2 incubator at 37°C. For transfections, 2 ϫ 10 6 cells were plated in 100-mm tissue culture dishes and transfected with appropriate plasmids for 18 h using LipofectAMINE reagent (Invitrogen/Life Technologies). After removal of the DNA mixture, the cells were incubated in Dulbecco's modified Eagle's medium/glutamine/ 0.1% BSA (Sigma Chemical Co.) until harvest 48 h after transfection.
To generate recombinant RGS16, we subcloned an EcoRI/XhoI fragment from pcDNA3-RGS16 into pET-28a (Novagen) in-frame with an amino-terminal hexahistidine tag. This plasmid was used as a PCR template for the production of the mutants described below. pET28a-RGS16 and pET15b-RGS2 were transformed into the Escherichia coli BL21(DE3)pLysS strain (Stratagene), and proteins were induced with 1 mM isopropyl-1-thio-␤-D-galactopyranoside for 3 h at 37°C. Recombinant proteins were purified by Ni 2ϩ /nitriloacetic acid-Sepharose (Qiagen) affinity chromatography per the manufacturer's instructions.
pcDNA3-HA-RGS16 (human) was the kind gift of Drs. Carol Beadling and Kendall Smith (Cornell University Medical College). We introduced tyrosine mutations into this plasmid using the QuikChange site-directed mutagenesis kit (Stratagene). We used the Y168F plasmid as a template for constructing Y168/Y177F. This plasmid was also used as a template to generate the complete RGS16 coding region by PCR, which was inserted into TOPO-pcDNA3-V5/His (Invitrogen) per the manufacturer's protocol. Constructs were confirmed by automated sequencing. The EGF receptor construct was a gift of Dr. Amyn Habib (Harvard University), and the plasmid encoding m2R was the kind gift of Dr. Silvio Gutkind (NIDCR, National Institutes of Health). Native EGFR kinase purified from A431 cells by lectin chromatography was purchased from Upstate Biotechnology Inc. PD153035 (Compound 32) was purchased from Calbiochem.
Immunoprecipitation and Immunoblotting-After hormone stimulation, we rinsed cells twice in ice-cold phosphate-buffered saline before lysis in buffer containing 150 mM NaCl, 50 mM Tris, pH 7.5, 5 mM EDTA, 0.25% deoxycholate, 1 mM NaF, 1% Nonidet P-40 along with 0.2 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride, and a mixture of protease inhibitors (Roche Molecular Biochemicals). We immunoprecipitated equal protein amounts (500 -600 g) with either rabbit polyclonal anti-HA (2 g ml Ϫ1 ) or anti-EGFR Ab (Santa Cruz Biotechnology). Antigen-antibody complexes were recovered using sheep antirabbit IgG magnetic beads (Dynal). Cells transfected with RGS16-V5/ His were lysed in buffer P (20 mM HEPES, pH 8, 150 mM NaCl, 10 mM ␤-mercaptoethanol, 15 mM imidazole, 1% Triton-X, 1 mM Na 3 VO 4 ). We extracted RGS16 from lysates with a 30-l slurry of Probond resin (Invitrogen). We washed the beads three times prior to addition of Laemmli buffer and SDS-PAGE. Antibodies against phospho-ERK, ERK1, EGFR, HA, and hexahistidine were from Santa Cruz Biotechnology, and anti-V5 was from Invitrogen. The signal was detected with Super Signal enhanced chemiluminescence (Pierce). Polyclonal anti-RGS16 raised against human His 6 RGS16 was the gift of Dr. Carol Beadling (Cornell University Medical College).
MAPK and Adenylyl Cyclase Assays-We carried out MAPK assays and measurements of receptor-stimulated cAMP as described previously except that cAMP levels were determined using the Biotrak radioimmunoassay as per the manufacturer's instructions (Amersham Pharmacia Biotech) (20) .
In Vitro Phosphorylation-We assayed RGS phosphorylation by incubating 10 pmol of His 6 RGS16 or His 6 RGS2 for 1 h at 30°C with native, purified EGFR in buffer containing 50 mM HEPES, pH 7.5, 5 mM MgCl 2 , 5 mM MnCl 2 , 1 mg ml Ϫ1 BSA, 0.1% Triton X-100, 1 mM Na 3 VO 4 , and [␥- Ϫ1 , indicating the presence of a single phosphorylation site. GAP Assays-We performed single turnover GTPase assays by loading recombinant, myristoylated G␣ i1 (purchased from Calbiochem) with [␥-
32 P]GTP (1 M, 50-100 cpm fmol Ϫ1 ) at 30°C in buffer containing 50 mM HEPES, pH 8, 5 mM EDTA, 1 mM dithiothreitol, 0.1% C 12 E 10 (buffer C). The reaction was chilled on ice before gel filtration on a Sepharose G-25 column that was equilibrated with buffer C plus BSA (0.1 mg ml Ϫ1 ). GTP hydrolysis was initiated by adding G protein to a tube containing unlabeled GTP (100 M) and MgSO 4 (10 mM) with or without RGS. Aliquots were removed at various time points from 10 s prior to start of the reaction (arbitrarily set as time zero) to 5 min and quenched in a chilled, activated charcoal/phosphoric acid slurry. Inorganic phosphate in supernatants was measured by liquid scintillation spectrometry after centrifugation at 1500 ϫ g. Net release of P i was determined by subtracting the amount at time zero, and rate constants (k cat ) were determined by fitting the data to a first order exponential function using SigmaPlot software (SSPI).
RESULTS

RGS Proteins Are Tyrosine-phosphorylated in Mammalian
Cells-Analysis of the amino acid sequence of mammalian RGS proteins revealed the presence of two highly conserved tyrosine residues that were potential sites of phosphorylation (Table I) . To determine if RGS proteins underwent tyrosine phosphorylation in mammalian cells, we expressed HA-RGS2, RGS4, and RGS16 in HEK 293T cells and treated the cells with the tyrosine phosphatase inhibitor sodium pervanadate. We immunoprecipitated RGS proteins with anti-HA antibody and immunoblotted them with anti-phosphotyrosine. Each of the three RGS proteins was phosphorylated on tyrosine residues in these cells after pervanadate treatment (Fig. 1) . We studied the tyrosine phosphorylation of RGS16 in detail, because it contains only these two tyrosine residues.
RGS16 Undergoes Tyrosine Phosphorylation in Response to m2R or EGFR Stimulation-To determine which extracellular stimuli induced RGS16 tyrosine phosphorylation, we transfected HEK 293T cells with a GPCR (m2 muscarinic), an RTK (EGFR), and HA-RGS16 and immunoblotted cell lysates with anti-phosphotyrosine. We detected tyrosine phosphorylation of HA-RGS16 in cells stimulated with carbachol ( Fig. 2A) . Surprisingly, EGF treatment induced strong RGS16 phosphorylation over a 1-to 15-min time period (Fig. 2B and data not shown). To determine whether RGS16 phosphorylation was specific, we used a selective inhibitor of EGFR kinase activity, Compound 32 (Cp32), which completely blocked EGF-induced RGS16 phosphorylation. To exclude the possibility that EGFinduced RGS16 phosphorylation was related to EGFR overexpression or the HA epitope tag, we utilized another cell line with high levels of endogenous EGFR, COS-7, and transfected 
EGFR-mediated RGS16 Tyrosine Phosphorylation
the cells with RGS16-V5/His. Recombinant RGS16 was extracted from detergent cell lysates by nickel affinity chromatography. In COS-7 cells, we observed phosphorylation of WT RGS16 after stimulation of endogenous EGFR, which was blocked by Cp32 (Fig. 2C, lane 4) and was not observed when RGS16 contained mutations of both tyrosine residues to phenylalanine (Y168/Y177F, lane 5). EGFR phosphorylation induced by EGF treatment was verified by immunoblotting.
GPCR-induced RGS16 Phosphorylation Is Dependent on EGFR Kinase Activity-Because EGF evoked strong RGS16 phosphorylation, we investigated which element of the EGFR signaling pathway was responsible for this effect and its potential role in GPCR-induced RGS16 phosphorylation. Because both GPCR and EGFR stimulation induce the activity of several non-receptor tyrosine kinases such as src or pyk2 (28, 29) , it was important first to distinguish whether EGFR itself or a downstream kinase-mediated RGS16 phosphorylation. We hypothesized that if m2R-induced RGS16 tyrosine phosphorylation required EGFR kinase activity, Cp32 would block carbachol-induced RGS16 phosphorylation. Not only did Cp32 prevent EGF-induced RGS16 phosphorylation, but it blocked m2R-induced phosphorylation as well (Fig. 2D) , suggesting direct involvement of the EGFR kinase in RGS16 phosphorylation.
Both RGS16 Tyrosine Residues Appear to Be Phosphorylated in 293T Cells-To determine which one or more RGS16 residues were phosphorylated, we expressed HA-RGS16-containing tyrosine to phenylalanine mutations in HEK 293T cells and treated the cells with EGF. EGF induced comparable phosphorylation of RGS16 (WT) and Y177F, whereas Y168F was phosphorylated to a lesser extent, and Y168/Y177F was not phosphorylated (Fig. 3) . These results indicate that both tyrosine residues may undergo phosphorylation after EGF treatment, although phosphorylation appeared to depend to a greater extent on the presence of residue Tyr 168 .
Mutation of Tyrosine Residues Abolishes RGS16 Regulation of GPCR-mediated MAPK Activation and Adenylyl Cyclase
Inhibition-To test whether the tyrosine residues were required for RGS16 regulation of GPCR-coupled MAPK activity in vivo, we measured m2R-induced MAPK activation in 293T cells expressing RGS16 (WT) or mutant proteins. There was no significant change in baseline MAPK activity in RGS16-transfected cells (Fig. 4A) . Carbachol induced a 5-fold increase in MAPK activity, which was inhibited ϳ70% by RGS16 (WT). In contrast, there was no significant difference in agonist-induced MAPK activation levels in cells transfected with empty vector or each of the three mutant proteins (Fig. 4B) . Differences between the activity of WT RGS16 and the tyrosine mutants were not likely due to a gross defect in RGS16 stability or localization, because all mutants were expressed at similar levels in detergent lysates (Fig. 4B, bottom) and in 100,000 ϫ g supernatants (data not shown).
To ascertain whether the effect of the tyrosine mutations on RGS16 inhibition of G i -mediated signaling was specific to the MAPK pathway, we tested the capacity of each mutant to 
FIG. 2. EGFR and GPCR stimulation induces RGS16 tyrosine phosphorylation.
A, carbachol-induced RGS16 tyrosine phosphorylation. HEK 293T cells were transfected with m2R (0.2 g), EGFR (0.2 g), and HA-RGS16 (3 g) and stimulated with carbachol (1 mM) for 5 min. A, or EGF (2 ng ml Ϫ1 ) for 0, 3, 7, and 15 min (B). Whole cell lysates were immunodetected with anti-phosphotyrosine (top panels) or anti-HA or anti-RGS16 (bottom panels). In lanes 2-5, cells were pretreated with Cp32 (500 pM) for 30 min prior to EGF stimulation. C, stimulation of endogenous EGFR in COS-7 cells induces RGS16 tyrosine phosphorylation. Cells transfected with RGS16-V5/His were stimulated with EGF (20 ng ml Ϫ1 for 5 min), and RGS16 was purified from detergent lysates by Ni 2ϩ affinity chromatography before immunoblotting with anti-phosphotyrosine (top panel) or anti-V5 (second panel from top). To verify EGFR stimulation, cell lysates (50 g of total protein) were resolved by SDS-PAGE and immunodetected with antiphosphotyrosine (third panel from top) or anti-EGFR (bottom panel). D, cells transfected with EGFR, m2R, and HA-RGS16 were stimulated with EGF (lanes 2 and 3) or carbachol (lanes 4 and 5) for 7 min. In lanesregulate another G i effector, adenylyl cyclase. We stimulated HEK 293T cells simultaneously through endogenous G s -(␤-adrenergic) and G i -coupled (somatostatin) receptors and measured inhibition of isoproterenol-induced cAMP by somatostatin. In vector-transfected cells, somatostatin inhibited the isoproterenol response by 36.5 Ϯ 1.9% (Fig. 4C) . In cells transfected with WT RGS16, cAMP generation was only inhibited by 8.1 Ϯ 2.4%, indicating that RGS16 blocked G i -mediated adenylyl cyclase inhibition (p Ͻ 0.0001). In contrast, we observed no significant diminution in somatostatin inhibition of the isoproterenol-induced response in cells transfected with each of the three mutant proteins. These data provide further evidence for the inability of Y168F, Y177F, or Y168/Y177F to regulate G imediated signaling.
Effect of Tyrosine Mutations on RGS16 GAP Activity-To determine the biochemical mechanism underlying the impaired function of the mutants in vivo, we tested the ability of recombinant RGS16 (WT) and mutant proteins to act as GAPs for G␣ i . GTP hydrolysis by G␣ i1 (200 nM) was determined during a single catalytic turnover in the presence or absence of RGS protein. We measured k cat for GTPase reactions containing a range of RGS16 WT or mutant concentrations (5-200 nM). When these values were expressed as a percentage of k cat for reactions containing the WT protein, Y168F exhibited 73% and Y168/Y177F 60.3% of WT activity, whereas Y177F had GAP activity similar to WT (p Ͻ 0.05, Y168F or Y168/177F versus WT; no significant difference between these two mutants) (Fig.  5) . These data suggest that Tyr 177 was not required for RGS16 GAP activity, whereas mutation of Tyr 168 to phenylalanine impaired the GAP activity of RGS16.
EGFR Phosphorylates RGS16 in Vitro-Because RGS16 tyrosine phosphorylation in 293T and COS-7 cells depended on EGFR kinase activity, we hypothesized that EGFR kinase phosphorylated RGS16 directly. To test this possibility, we incubated recombinant His 6 RGS16 with purified EGFR and [␥-32 P]ATP. EGFR phosphorylated RGS16 (WT) but not RGS16 (Y168/177F) or His 6 RGS2 (Fig. 6A) . To determine which residue might be phosphorylated by purified EGFR, single-or double-tyrosine mutants were incubated with the kinase and immunoblotted with anti-phosphotyrosine. WT RGS16 and Y177F were phosphorylated to a similar extent, whereas neither Y168F nor Y168/177F were phosphorylated (Fig. 6B) . This result suggests that EGFR phosphorylates RGS16 specifically on Tyr 168 , although these studies must be confirmed by phosphoamino acid mapping.
Co-immunoprecipitation of EGFR and RGS16 -To determine whether RGS16 interacted with EGFR in cells, we expressed the two proteins in 293T cells and immunoprecipitated EGFR with a specific antibody. A band corresponding to HA-RGS16 was observed in EGFR immunoprecipitates regardless of whether the cells were stimulated with EGF (Fig. 7A) . This result suggested an association between RGS16 and EGFR that was independent of EGFR activation. To exclude the possibility that co-immunoprecipitation was a result of EGFR overexpression, we transfected COS-7 cells with RGS16 V5/His and extracted RGS16 protein with Ni 2ϩ beads. After extensive 
FIG. 4. Importance of tyrosine residues for RGS16 regulation of m2R-induced MAPK activation and adenylyl cyclase inhibition.
A, 293T cells transfected with m2R and HA-RGS16 WT or mutants were stimulated with carbachol (1 mM) for 5 min at 37°C. Phospho-ERK immunoblots were quantitated using IPLab Gel software, and activity is expressed as the -fold increase over that found in unstimulated, vector-transfected cells (column 1). The bar graph depicts MAPK activity (mean Ϯ S.E.) derived from three independent experiments. (*p Ͻ 0.01 between WT and mutants, **p Ͻ 0.005 between vector and WT; no significant difference between unstimulated rates or between agonist-stimulated activity of vector and mutant transfectants, t test.) B, blots of whole cell lysates were immunodetected with anti-phosphospecific ERK (top), anti-ERK1 (middle), and anti-HA Ab (bottom). Shown is a single experiment representative of three similar experiments. C, inhibition of isoproterenol-induced adenylyl cyclase activity by somatostatin in 293T cells expressing WT and mutant RGS16 proteins. The bar graph depicts the percent inhibition of isoproterenolinduced cAMP by simultaneous somatostatin stimulation (mean Ϯ S.E. of four independent experiments; *p Ͻ 0.05, WT versus Y168F or Y168/177F; **p Ͻ 0.005, vector versus WT or WT versus Y177F; no significant difference between vector and mutants).
washing, we immunoblotted for endogenous EGFR. EGFR bound only to beads containing RGS16 (Fig. 7B) .
EGFR-mediated Phosphorylation Stimulates RGS16 GAP
Activity-To test whether EGFR-mediated RGS16 phosphorylation affected RGS16 GAP activity directly, we measured G␣ i1 GTPase rates in the presence of RGS16 preincubated or not with purified EGFR. k cat for G␣ i1 GTP hydrolysis at 4°C was 0.006 Ϯ 0.001 s Ϫ1 . Rate constants for reactions containing RGS16 from 1 to 50 nM increased linearly, from 2-to 20-fold over basal rates. Surprisingly, at each RGS16 concentration, k cat values for reactions containing phosphorylated RGS16 (pRGS16) were nearly 2-fold higher than those containing unmodified RGS16, which was statistically significant (Fig. 8A , p Ͻ 0.05, paired t test). To eliminate variability in rate constants due to different RGS16 preparations and differing stoichiometries of phosphorylation from individual reactions, we determined k cat values for reactions containing pRGS16 from independent phosphorylation assays. We normalized these values to rate constants for reactions containing unmodified RGS16. The average k cat for reactions containing 25 and 50 nM pRGS16 was 180% Ϯ 0.3% of the control values (Fig. 8B , p Ͻ 0.05 between RGS16 and pRGS16; no statistical difference between the two concentrations). There was no effect of EGFR 
FIG. 6. EGFR kinase phosphorylation of RGS16 requires Tyr
168
. A, His 6 RGS16 (WT), His 6 RGS16 (Y168/177F), or His 6 RGS2 (500 ng) were incubated with 3 nM EGFR and radiolabeled ATP. Proteins were resolved by SDS-PAGE, and gels were dried prior to autoradiography (top and middle). In parallel, each protein (5 g) was run on a separate gel before staining with Coomassie Blue to verify protein integrity (bottom). B, purified EGFR was incubated with His 6 RGS16 WT or mutants and unlabeled ATP. Proteins were separated by SDS-PAGE and immunodetected with anti-phosphotyrosine or anti-RGS16 antibodies as indicated.
FIG. 7. EGFR co-immunoprecipitates with RGS16.
A, EGFR, pcDNA3, or pcDNA3-HA-RGS16 were expressed in HEK 293T cells. 48 h after transfection, cells lysates were prepared after a 7-min stimulation with medium alone (lanes 1 and 2) or EGF (10 ng ml Ϫ1 , lanes 3 and 4). EGFR was immunoprecipitated with a specific antibody before resolution by SDS-PAGE and immunodetection with anti-EGFR (top) or HA (bottom). B, COS-7 cells containing endogenous EGFR were transfected with RGS16-V5/His or empty vector. RGS16 was extracted from detergent lysates by nickel affinity chromatography before immunoblotting with anti-EGFR or anti-V5 as indicated. In contrast to HA-RGS16, RGS16-V5/His migrates just above the 26-kDa marker on SDS-PAGE, presumably due to the epitope tag. Protein from post-IP supernatants was run in parallel (bottom panel) and immunodetected with anti-EGFR to ensure that the total amount of EGFR in lysates was not limiting.
on RGS16 (Y168F) GAP activity. The EGFR preparation had no GTPase activity in the absence of G protein, nor did EGFR exhibit GAP activity toward G␣ i1 (data not shown). Overall, these data suggest that EGFR-induced phosphorylation directly stimulated the GAP activity of RGS16.
DISCUSSION
This study supports the notion that two conserved tyrosine residues in RGS16 are phosphorylated and necessary to regulate G␣ i -mediated MAPK activation and inhibition of adenylyl cyclase activity. Because EGFR and RGS16 co-immunoprecipitated in two different cell lines and because EGF stimulation resulted in phosphorylation of RGS16 that depended on Tyr 168 and, to a lesser extent, Tyr 177 , a functional interaction between EGFR and RGS16 likely exists. In addition, because EGF stimulation induces the activation of other tyrosine kinases, another enzyme could be responsible for phosphorylation of residue Tyr 177 , because purified EGFR did not phosphorylate RGS16 (Y168F). Alternatively, phosphorylation could depend on the presence of both tyrosine residues.
Tyrosine phosphorylation regulates the activity of many G protein-signaling components. For example, a tyrosine-phosphorylated, G protein-dependent Ca 2ϩ channel interacts with the phosphotyrosine binding domain of RGS12, resulting in enhanced G protein deactivation and attenuated channel activity (30) . Phosphotyrosines in the cytoplasmic tail of RTKs serve as a scaffold to which other signaling proteins are recruited (31) .
Tyrosine phosphorylation may also alter protein conformation to modulate activity, as is the case for src kinase (32) .
We found that EGFR-mediated phosphorylation increased RGS16 GAP activity in vitro, suggesting that it might affect RGS16 conformation directly. NMR analysis of "free" RGS4 versus RGS4 complexed with AlF4-G␣ i1 indicates that a kink in helix 6 between residues Lys 116 and Tyr 119 (Lys 165 to Tyr 168 in RGS16) is more pronounced upon G protein binding (33) . Because Tyr 168 is situated in this region and is located between RGS residues critical for G␣ interaction (34), its phosphorylation could potentially play a role in this conformational change and modification of the RGS-G␣ interface. Notably, the increase in pRGS16 activity is probably underestimated by our studies, (a) because of possible sub-maximal stoichiometry of RGS16 phosphorylation and (b) because of inherent limitations in single turnover GTPase assays. For example, RGS2 GAP activity toward G␣ i is undetectable in traditional single turnover assays but becomes readily apparent when agonist-stimulated GTPase activity of G␣ i is measured in proteoliposomes reconstituted with both a GPCR and heterotrimeric G protein (35) . A similar strategy might uncover larger differences in RGS16 GAP activity in the presence and absence of phosphorylation.
Interestingly, although RGS16 phosphorylation after stimulation of the G i -linked m2R was relatively low, mutation of either tyrosine residue almost completely abolished the activity of RGS16 as an inhibitor of G i -mediated signal transduction. This discrepancy might be explained by several factors. First, the Y168F mutation alone diminished RGS16 GAP activity in vitro and, thus, may contribute to the absent activity of RGS16(Y168F) in cells independent of phosphorylation. Second, fractional RGS16 phosphorylation after m2R stimulation may have been artificially low due to the high amounts of transfected RGS16 relative to the amount of tyrosine kinase available. Third, RGS16 overexpression may block m2R-induced EGFR transactivation, resulting in diminution of carbachol-induced RGS16 phosphorylation, because it depends on EGFR activation. In any case, the fact that significant differences in the activity of RGS16 versus phosphorylated RGS16 exist in the context of relatively weak phosphorylation argues for the vital importance of tyrosine phosphorylation to RGS16 biological function. Confirmation of these data awaits studies of endogenous RGS16 in native mammalian systems.
Further evidence that tyrosine phosphorylation regulates RGS16 function is that residue Tyr 177 also appears to be phosphorylated after EGF stimulation. Mutation of Tyr 177 to phenylalanine prevented RGS16 from attenuating G protein-mediated MAPK activation or adenylyl cyclase inhibition without affecting GAP activity in vitro, suggesting that phosphorylation of Tyr 177 might control another aspect of RGS16 function in cells. Phosphorylation could modify RGS16 localization, stability, or protein-protein interactions independent of its GAP activity. One such possibility is the alteration of interactions of pRGS16 with anionic membrane phospholipids, which may directly affect RGS GAP activity (19) . Further studies will be needed to evaluate how phosphorylation of this residue affects RGS16 function and to determine which kinase is responsible for Tyr 177 phosphorylation. Tyrosine phosphorylation could also influence the selectivity of RGS proteins in vivo. RGS2, -4, and -16 were phosphorylated on tyrosine residues in 293T cells after pervanadate treatment, yet EGFR selectively phosphorylated only RGS4 and RGS16 (Fig. 4A and data not shown) . The sequence upstream of the residue equivalent to Tyr 168 in RGS2 differs from both RGS4 and 16 (Table I ), suggesting that flanking sequences may determine kinase recognition. In addition, the residue analogous to RGS16 Tyr 168 in RGS5 is Leu, implying that RGS5 is not phosphorylated by EGFR at this site. Thus, tyrosine phosphorylation of select RGS proteins expressed in the same cell may determine their effect on a particular G protein or GPCR pathway.
Unexpectedly, we found that GPCR-induced RGS16 phosphorylation was dependent upon on EGFR kinase activity. GPCRs activate a number of cytoplasmic tyrosine kinases as well as RTKs such as EGFR (28, 29, 36 -38) . For instance, both GTP-bound G␣ i and G␣ s stimulate src kinase activity directly (29) . We hypothesized that m2R stimulation, which is coupled to G␣ i , would induce strong RGS16 phosphorylation if src were the primary kinase involved. Instead, we found that m2R-mediated RGS16 phosphorylation required EGFR kinase activity. These results do not exclude a direct role for src or other kinases in RGS16 phosphorylation, however.
Cross-talk between GPCRs and RTKs is well documented (36 -38) . The mitogenic effects of G i -or G q -coupled receptors may require EGFR tyrosine phosphorylation and kinase activity (36, 38) . Our results suggest that this RTK potentially inhibits G protein signaling in a feedback loop by enhancing the activity of a GAP. The rate of G␣ i deactivation might be faster in the presence of phosphorylated RGS16, resulting in decreased downstream G protein effector stimulation. It will be of interest to determine if other RTKs (e.g. insulin receptor or platelet-derived growth factor receptor) phosphorylate RGS16 and to study the effect of EGFR-induced RGS16 phosphorylation on the activation of both RTK-and GPCR-induced biological end points.
